The rising interest in GLP-1 agonists for diabetes has led to a discussion about formats: patches versus tablets . Usually , GLP-1 therapies were only available in pill form, but the development of https://mohamadweno629746.blogvivi.com/41538682/glp-1-skin-applications-vs-oral-medications-is-right-for-the-patient